Ellipsys经皮与近端前臂Gracz型手术动静脉内瘘的比较
本研究回顾性比较了Ellipsys经皮动静脉内瘘与近端前臂Gracz型手术动静脉内瘘。经皮组89例,手术组69例,技术成功率均100%,经皮组手术时间更短(14 vs 74分钟)。两组次级通畅率无差异,但近端桡动脉手术内瘘的次级通畅失败率高于经皮组(34% vs 12%,P=0.04)。
要点
- 经皮与手术AVF技术成功率均达100%,次级通畅率相近。
- 经皮AVF手术时间显著短于手术AVF(14 vs 74分钟,P<0.001)。
- 近端桡动脉手术AVF的12个月次级通畅失败率高于经皮AVF(34% vs 12%,P=0.04)。
核心结论
- 经皮和手术AVF均具有高技术成功率和次级通畅率,经皮AVF手术时间更短,干预率相似。
研究设计与样本
- 回顾性研究,分析前瞻性收集的34个月内所有血管通路手术,经皮AVF组89例,手术AVF组69例。
主要发现
- 技术成功率两组均为100%,平均手术时间经皮组14分钟,手术组74分钟(P<0.001)。
- 12个月初级通畅失败累积发生率手术组47%,经皮组64%(P=0.1),次级通畅失败两组分别为20%和12%(P=0.3)。
- 近端桡动脉手术AVF与经皮AVF的12个月初级通畅率相似(65% vs 64%,P=0.8),但次级通畅失败率更高(34% vs 12%,P=0.04)。
关键数值与推荐
- 经皮AVF均使用近端桡动脉作为流入道;手术AVF流入道包括桡动脉(30%)、尺动脉(12%)和肱动脉(58%)。
- 两组流出道静脉均为头静脉和/或贵要静脉。
- 访问流量、成熟时间和每患者年干预总数无显著差异。
临床怎么用
- 当远端桡动脉AVF不可行时,经皮AVF可作为安全有效的选择,并保留近端前臂手术AVF的后续创建选项。
局限性
- 回顾性研究,随访时间相对较短,且研究结束时并非所有患者都需要血液透析。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RATIONALE & OBJECTIVE: Percutaneous arteriovenous fistulas (AVF) are created by establishing a proximal forearm anastomosis and offer a safe and reliable vascular access. This study compares the Ellipsys percutaneous AVF with a proximal forearm Gracz-type surgical AVF, chosen for comparison as it is constructed at the same anatomical site. STUDY DESIGN: Retrospective study of prospectively collected clinical data. SETTING & PARTICIPANTS: All vascular access procedures conducted during a 34-month period were reviewed. The study groups comprised 89 percutaneous AVFs and 69 surgical AVFs. EXPOSURE: Percutaneous or surgical AVF placement. OUTCOME: AVF patency, function, and complications. ANALYTICAL APPROACH: Patency rates for each AVF group were evaluated by competing risk survival analysis using a cumulative incidence function. Association of primary, primary assisted, and secondary patency with the AVF groups was examined by Cox proportional hazard models. RESULTS: Technical success was 100% for both groups. Average procedure times were 14 minutes for percutaneous AVFs and 74 minutes for surgical AVFs (P < 0.001). Proximal radial artery (PRA) was used in all percutaneous AVF cases. Inflow for surgical AVFs included radial (30%), ulnar (12%), and brachial (58%) arteries. Outflow veins for both groups were the cephalic and/or basilic veins. Access flow volumes, times to maturation, and overall numbers of interventions per patient-year were not significantly different. Cumulative incidence of primary patency failure at 12 months was lower for surgical AVF (47% vs 64%, P = 0.1), but secondary patency failure was not different between groups (20% vs 12%, P = 0.3). PRA surgical AVFs had similar primary patency (65% vs 64%, P = 0.8) but higher secondary patency failure rates than percutaneous AVFs at 12 months (34% vs 12%, P = 0.04). LIMITATIONS: Retrospective study with a relatively short follow-up period, and not all patients required hemodialysis at the end of study. CONCLUSIONS: Both percutaneous and surgical AVFs demonstrated high rates of technical success and secondary patency. Percutaneous AVFs required shorter procedure times. The rate of intervention was similar. When a distal radial artery AVF is not feasible, percutaneous AVF might offer an appropriate procedure for creating a safe and functional access, maintaining further proximal forearm surgical AVF creation options.
引用
- Shahverdyan R, Beathard G, Mushtaq N, et al. Comparison of Ellipsys Percutaneous and Proximal Forearm Gracz-Type Surgical Arteriovenous Fistulas. Am J Kidney Dis. 2021. PMID: 33662481. doi:10.1053/j.ajkd.2021.01.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。